Loading…
BOOTS ALLERGY RELIEF is a brand name for Fluticasone. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Nasofan Allergy 50 microgram Nasal Spray is indicated for the prophylaxis and treatment of allergic rhinitis including hay fever and that caused by other airborne allergens such as house dust mite and animal dander. Nasofan Allergy 50 microgram Nasal Spray provides symptomatic relief of sneezing, itchy and runny nose,…
Verbatim from this product's MHRA label. Tap a section to expand.
Nasofan Allergy 50 microgram Nasal Spray is for administration by the intranasal route only. Shake the bottle gently before each use. Prior to first use Nasofan Allergy 50 microgram Nasal Spray must be primed by pressing down and releasing the pump six times.
If Nasofan Allergy 50 microgram Nasal Spray has not been used for 7 days it must be reprimed by pressing down and releasing the pump a sufficient number of times until a fine mist is produced.
Adults aged 18 years and over:
For the prophylaxis and treatment of allergic rhinitis:- Two sprays into each nostril once a day (200 mcg) preferably in the morning is recommended. In some cases two sprays into each nostril twice a day (400 mcg) may be required. Once symptoms are under control a maintenance dose of one spray per nostril once a day (100 mcg) may be used.
If symptoms recur the dosage may be increased accordingly. The maximum daily dose should not exceed four sprays into each nostril (400 mcg). The minimum dose at which the effective control of symptoms is maintained should be used. The maximum daily dose should not exceed four sprays into each nostril.
Elderly patients:
The normal adult dosage is applicable.
Children and adolescents under 18 years of age:
Should not be used by children and adolescents under 18 years of age. Prophylaxis of allergic rhinitis requires treatment before contact with allergen. For full therapeutic benefit regular usage is recommended. Maximum benefit may require 3-4 days of continuous treatment in some people.
The most frequently reported side effects were epistaxis (> 1/10) followed by headache, unpleasant taste and smell, dryness and irritation of the nose, dryness and irritation of the pharynx (> 1/100 to < 1/10) Adverse events are listed below by system organ class and frequency.
Frequencies are defined as: very common (>1/10), common (>1/100 and <1/10), uncommon (>1/1000 and <1/100), rare (>1/10,000 and <1/1000), very rare (<1/10,000) not known (cannot be estimated from the available data). System Organ Class Adverse Event Frequency Hypersensitivity reactions with the following manifestations: Bronchospasm Rare Anaphylactic reactions Rare Anaphylactoid reactions Rare Cutaneous hypersensitivity reactions Very rare Immune system disorders Angioedema (mainly facial and oropharyngeal oedema) Very rare Nervous system, disorders Headache, unpleasant taste, unpleasant smell.
Common Glaucoma, raised intraocular pressure, cataract These events have been identified from spontaneous reports following prolonged treatment. Very rareEye disorders Vision, blurred (see also section “Special warnings and precautions for use”) Not Known.
Epistaxis Very common Nasal dryness, nasal irritation, throat dryness, throat irritation Common Nasal septal perforation*, mucocutaneous ulceration Usually in patients who have had previous nasal surgery. Very rare Respiratory, thoracic and mediastinal disorders Nasal ulcers Not known *Cases of perforation of the nasal septal wall have been reported as a result of the use of corticosteroids.
As with other nasal sprays, dryness and irritation of the nose and throat, unpleasant taste and smell, epistaxis and headache have been reported. Extremely rare cases of nasal ulceration and nasal septal perforation have been reported following the use of intranasal corticosteroids, usually in patients who have had previous nasal surgery.
Administration of treatment may be necessary for several days for the full benefit of Nasofan Allergy 50 microgram Nasal Spray to be achieved. Upon transferring patients from systemic steroid treatment to Nasofan Allergy 50 microgram Nasal Spray, care must be taken if there is any reason to suppose that their adrenal function is impaired.
Treatment should be stopped or the advice of a doctor sought if an improvement is not seen within 7 days. The advice of a doctor or pharmacist should also be sought if symptoms have improved but are not adequately controlled. Nasofan Allergy 50 microgram Nasal Spray should not be used for more than 3 months continuously without consulting a doctor.
Medical advice should be sought before using Nasofan Allergy 50 microgram Nasal Spray in the case of; • concomitant use of other corticosteroid products, such as tablets, creams, ointments, asthma medications, similar nasal sprays or eye/nose drops.
• an infection in the nasal passages or sinuses. • recent injury or surgery to the nose, or problems with ulceration in the nose. In most cases Nasofan Allergy 50 microgram Nasal Spray will control seasonal allergic rhinitis, however in the event of an abnormally heavy challenge of summer allergens appropriate additional therapy may be necessitated in certain instances.
Such an instance may particularly be to control eye symptoms. Systemic effects of nasal corticosteroids may occur, particularly at high doses prescribed for prolonged periods. These effects are much less likely to occur than with oral corticosteroids and may vary in individual patients and between different corticosteroid preparations.
Potential systemic effects may include Cushing’s syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, cataract, glaucoma and more rarely, a range of psychological or behavioural effects including psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in children).
1
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Fluticasone in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
4 “Special warnings and precautions for use”). Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
2. Visual disturbance Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible cause which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.
Adrenal suppression may occur to clinically significant levels as a result of treatment with higher than recommended doses of nasal corticosteroids. 1 for data on intranasal fluticasone propionate). g. ketoconazole and protease inhibitors such as ritonavir) may occur.
g. Cushing’s Syndrome and adrenal suppression have been observed). Therefore concomitant use of fluticasone propionate and ritonavir should be avoided unless the expected benefit exceeds the possible risk of systemic adverse reaction of corticosteroids.
5 “Interaction with other medicinal products and other forms of interaction”). In patients who have tuberculosis, any type of untreated infection, ocular herpes or have had a recent surgical operation or injury to the nose or mouth, the possible benefits of the treatment should be weighed against possible hazards.
Local infections: infections of the nasal airways should be appropriately treated but do not constitute a specific contraindication to treatment with Nasofan Allergy 50 microgram Nasal Spray. Nasofan Allergy 50 microgram Nasal Spray contains benzalkonium chloride.
Irritant may cause skin reactions. If used for longer periods, the preservative benzalkonium chloride may cause nasal mucosa swelling. In the case of such a reaction (persistently congested nose) then preservative-free medicinal products for nasal use should be used if possible; however if such preservative-free medicinal products are not available another pharmaceutical form should be taken.